Health Funding

Health economist Peter Huskinson analyses the Budget’s real-terms health spend per person and how this compares to previous years 

The National Annual Agreement Review meeting scheduled for yesterday was postponed for a second time because Te Whatu Ora is still not ready to make a funding uplift offer to pharmacy representatives

General practice has been offered a 4 per cent funding uplift by Health NZ Te Whatu Ora in their annual contract talks. Is this a sign of what is coming for the pharmacy sector at the upcoming National Annual Agreement Review (NAAR) meeting on Monday?

Kaupapa Māori healthcare providers are facing wide-ranging funding cuts on 30 June, following the disestablishment of Te Aka Whai Ora

The rapid-response home-visiting team of Auckland outreach vaccination service, Uri Ririki Child Health Connection Centre, will be disestablished at the end of this month

The National Annual Agreement Review meeting planned for tomorrow has been postponed until 24 June because Health New Zealand Te Whatu Ora does not yet know how much money it will allocate to pharmacy funding

The lack of additional investment in New Zealand’s medicines budget, especially the failure to announce the funding of 13 cancer-drug treatments promised before the election is extremely disappointing

Budget 2024: Aside from a glaring hole where new funding for Pacific providers should be, there are no surprises in the Vote Health section of the 2024 Budget, says public health academic Sir Collin Tukuitonga

Budget 2024: Health economist Paula Lorgelly says many Kiwis who were expecting more funding for new cancer drugs and for Pharmac will be sadly disappointed by Budget 2024, which she sees as underwhelming. 

The return of the $5 prescription fee for most people is the main change for New Zealand’s health system in Budget 2024